Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Biomarkers in Medicine
|
April 14, 2010
Accelerating Development and Advancing Personalized Therapy (ADAPT) Congress. Washington, DC, USA, 22-25 September 2009
Beverly C Handy
Clinical Biochemistry
|
July 11, 2015
Falsely elevated tacrolimus concentrations on the Dimension Xpand
Qing H Meng, Beverly C Handy, Elizabeth A Wagar
Pathology
|
March 9, 2019
Biclonal presentation of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia
Wei Wang, Yi Ding, Andrew Campbell, et al.
American Journal of Clinical Pathology
|
April 22, 2005
Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients
Pei Lin, Suyang Hao, Beverly C Handy, et al.
Archives of Pathology & Laboratory Medicine
|
March 17, 2018
Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer
Liyun Cao, Chi Hyun Lee, Jing Ning, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 12, 2016
Causes and impact of specimen rejection in a clinical chemistry laboratory
Liyun Cao, Meng Chen, Ron A Phipps, et al.
American Journal of Clinical Pathology
|
March 4, 2005
Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein
C Cameron Yin, Pei Lin, Dennis A Carney, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 28, 2010
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer
Ugo De Giorgi, Michal Mego, Eric M Rohren, et al.
Breast Cancer Research and Treatment
|
December 18, 2012
Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer
Windy Dean-Colomb, Kenneth R Hess, Elliana Young, et al.
Breast Cancer Research : BCR
|
June 25, 2011
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano, Antonio Giordano, Summer Jackson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Biomarkers in Medicine
|
April 14, 2010
Accelerating Development and Advancing Personalized Therapy (ADAPT) Congress. Washington, DC, USA, 22-25 September 2009
Beverly C Handy
Clinical Biochemistry
|
July 11, 2015
Falsely elevated tacrolimus concentrations on the Dimension Xpand
Qing H Meng, Beverly C Handy, Elizabeth A Wagar
Pathology
|
March 9, 2019
Biclonal presentation of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia
Wei Wang, Yi Ding, Andrew Campbell, et al.
American Journal of Clinical Pathology
|
April 22, 2005
Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients
Pei Lin, Suyang Hao, Beverly C Handy, et al.
Archives of Pathology & Laboratory Medicine
|
March 17, 2018
Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer
Liyun Cao, Chi Hyun Lee, Jing Ning, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 12, 2016
Causes and impact of specimen rejection in a clinical chemistry laboratory
Liyun Cao, Meng Chen, Ron A Phipps, et al.
American Journal of Clinical Pathology
|
March 4, 2005
Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein
C Cameron Yin, Pei Lin, Dennis A Carney, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 28, 2010
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer
Ugo De Giorgi, Michal Mego, Eric M Rohren, et al.
Breast Cancer Research and Treatment
|
December 18, 2012
Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer
Windy Dean-Colomb, Kenneth R Hess, Elliana Young, et al.
Breast Cancer Research : BCR
|
June 25, 2011
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano, Antonio Giordano, Summer Jackson, et al.
Page
of 2